Literature DB >> 30535628

Advance for Cardiovascular Health in China.

Yihua Bei1, Chao Shi1, Zhongrong Zhang1, Junjie Xiao2.   

Abstract

As the most populous country worldwide, China has ≈ 290 million patients with cardiovascular diseases (CVDs), representing the leading cause of death in Chinese population. The morbidity and mortality of CVDs are continuously rising. Here, we will first summarize the recent advance in the management of CVDs such as coronary arterial disease, arrhythmia, and heart failure in China. In particular, we will introduce the development of chest pain centers and indicate the novel techniques and methods applied for the management of CVDs. Then, we will discuss and point out the importance of improving the clinical and basic research for Traditional Chinese medicine in the treatment of CVDs. Finally, we will emphasize the efforts made to promote cardiac rehabilitation and cardiovascular prevention system in China. We are striving to establish a practical prevention-treatment-rehabilitation system and looking forward to a bright future with reduced morbidity and mortality from CVDs in China.

Entities:  

Keywords:  Cardiovascular diseases; China; Prevention; Rehabilitation; Treatment

Mesh:

Year:  2018        PMID: 30535628     DOI: 10.1007/s12265-018-9852-7

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  32 in total

1.  Accidental Extraction of a Stent Implanted 3 Years Earlier by a Dislodged Stent: A Rare Complication of Percutaneous Coronary Intervention.

Authors:  Qing Qin; Jianying Ma; Chenguang Li; Lei Ge; Juying Qian; Junbo Ge
Journal:  JACC Cardiovasc Interv       Date:  2015-09-17       Impact factor: 11.195

2.  Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study.

Authors:  Yonathan F Melman; Ravi Shah; Kirsty Danielson; Junjie Xiao; Bridget Simonson; Andreas Barth; Khalid Chakir; Gregory D Lewis; Zachary Lavender; Quynh A Truong; Andre Kleber; Ranendra Das; Anthony Rosenzweig; Yaoyu Wang; David Kass; Jagmeet P Singh; Saumya Das
Journal:  Circulation       Date:  2015-05-20       Impact factor: 29.690

3.  Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.

Authors:  Runlin Gao; Yuejin Yang; Yaling Han; Yong Huo; Jiyan Chen; Bo Yu; Xi Su; Lang Li; Hai-Chien Kuo; Shih-Wa Ying; Wai-Fung Cheong; Yunlong Zhang; Xiaolu Su; Bo Xu; Jeffery J Popma; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2015-10-12       Impact factor: 24.094

4.  First report of stent thrombosis after a switch therapy resulting from ticagrelor-related dyspnea.

Authors:  Hongyi Wu; Qibing Wang; Jingmin Zhou; Juying Qian; Junbo Ge
Journal:  Int J Cardiol       Date:  2014-08-05       Impact factor: 4.164

5.  Neprilysin inhibition--a novel therapy for heart failure.

Authors:  Mariell Jessup
Journal:  N Engl J Med       Date:  2014-08-30       Impact factor: 91.245

6.  miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling.

Authors:  Xiaojun Liu; Junjie Xiao; Han Zhu; Xin Wei; Colin Platt; Federico Damilano; Chunyang Xiao; Vassilios Bezzerides; Pontus Boström; Lin Che; Chunxiang Zhang; Bruce M Spiegelman; Anthony Rosenzweig
Journal:  Cell Metab       Date:  2015-04-07       Impact factor: 27.287

7.  A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.

Authors:  Xinli Li; Jian Zhang; Jun Huang; Aiqun Ma; Jiefu Yang; Weimin Li; Zonggui Wu; Chen Yao; Yuhui Zhang; Wenming Yao; Boli Zhang; Runlin Gao
Journal:  J Am Coll Cardiol       Date:  2013-06-07       Impact factor: 24.094

8.  Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Authors:  Yaling Han; Jincheng Guo; Yang Zheng; Hongyun Zang; Xi Su; Yu Wang; Shaoliang Chen; Tiemin Jiang; Ping Yang; Jiyan Chen; Dongju Jiang; Quanmin Jing; Zhenyang Liang; Haiwei Liu; Xin Zhao; Jing Li; Yi Li; Bo Xu; Gregg W Stone
Journal:  JAMA       Date:  2015-04-07       Impact factor: 56.272

9.  Can the Prognosis of Cardiac Resynchronization Therapy Be Predicted by Gated SPECT?

Authors:  Shengmei Qin; Hongcheng Shi; Yangang Su; Shuguang Chen; Wenzhi Pan; Junbo Ge
Journal:  Clin Nucl Med       Date:  2015-10       Impact factor: 7.794

10.  Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice.

Authors:  Lichan Tao; Sutong Shen; Siyi Fu; Hongyi Fang; Xiuzhi Wang; Saumya Das; Joost P G Sluijter; Anthony Rosenzweig; Yonglan Zhou; Xiangqing Kong; Junjie Xiao; Xinli Li
Journal:  Sci Rep       Date:  2015-02-11       Impact factor: 4.379

View more
  7 in total

1.  Association between heart rate and cardiovascular death in patients with coronary heart disease: A NHANES-based cohort study.

Authors:  Ruicong Ma; Jianbo Gao; Shiyuan Mao; Zhirong Wang
Journal:  Clin Cardiol       Date:  2022-03-30       Impact factor: 3.287

2.  Quality indicators for cardiac rehabilitation after myocardial infarction in China: a consensus panel and practice test.

Authors:  Xianghui Zheng; Maomao Zhang; Yang Zheng; Yongxiang Zhang; Junnan Wang; Ping Zhang; Xuwen Yang; Shan Li; Rongjing Ding; Gaowa Siqin; Xinyu Hou; Liangqi Chen; Min Zhang; Yong Sun; Jian Wu; Bo Yu
Journal:  BMJ Open       Date:  2020-12-30       Impact factor: 3.006

3.  Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis.

Authors:  Xiaopeng Guo; Yishan Guo; Zhiwen Wang; Bingxin Cao; Chuansheng Zheng; Zhuanglin Zeng; Yumiao Wei
Journal:  Oxid Med Cell Longev       Date:  2022-03-29       Impact factor: 6.543

4.  Daily intake of up to two eggs for 11 weeks does not affect the cholesterol balance of Chinese young adults.

Authors:  Zhili Ma; Wei Wu; Dexin Zhang; Ping Wu; Yuanhua Guo; Deyuan Li; Fang Yang
Journal:  Food Sci Nutr       Date:  2022-01-17       Impact factor: 2.863

5.  Mechanism of Action of Zhi Gan Cao Decoction for Atrial Fibrillation and Myocardial Fibrosis in a Mouse Model of Atrial Fibrillation: A Network Pharmacology-Based Study.

Authors:  Lei Gao; Chenjing Kan; Xin Chen; Shengsong Xu; Kaihu Shi
Journal:  Comput Math Methods Med       Date:  2022-06-09       Impact factor: 2.809

6.  The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure.

Authors:  Qiulian Zhou; Li-Long Pan; Ruicong Xue; Gehui Ni; Yi Duan; Yuzheng Bai; Chao Shi; Zhengnan Ren; Chengfei Wu; Guoping Li; Birgitta Agerberth; Joost Pg Sluijter; Jia Sun; Junjie Xiao
Journal:  Theranostics       Date:  2020-05-15       Impact factor: 11.556

Review 7.  Current Studies and Future Directions of Exercise Therapy for Muscle Atrophy Induced by Heart Failure.

Authors:  Qi Liu; Juan Gao; Jiali Deng; Junjie Xiao
Journal:  Front Cardiovasc Med       Date:  2020-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.